How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example

Published:2018-10 Issue:10 Volume:125 Page:1485-1487
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Chiang Michael F.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference27 articles.

1. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results;Arch Ophthalmol,1988

2. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial;Arch Ophthalmol,2003

3. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N Engl J Med,1994

5. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate;Adamis;Arch Ophthalmol,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis;Frontiers in Pediatrics;2023-08-04

2. Recurrence risk factors of intravitreal ranibizumab monotherapy in retinopathy of prematurity: a retrospective study at one center;International Journal of Ophthalmology;2023-01-18

3. Effect of ranibizumab on retinopathy of prematurity: A meta-analysis;Frontiers in Pharmacology;2022-08-22

4. Challenges in Elucidating Ophthalmology’s Standards of Care;JAMA Ophthalmology;2022-02-01

5. The 2021 National Eye Institute Strategic Plan: Eliminating Vision Loss and Improving Quality of Life;Ophthalmology;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3